month to month glp 1 GLP-1/GIP Results After 1, 3, and 6 Months Medicare covers GLP-1s for $50/month

PlexusDx semaglutide injections, tirzepatide, and other GLP-1 formulations are HSA and FSA eligible when prescribed by a licensed provider

Sensitivity analysis To assess the robustness of our findings, we conducted leave-one-out sensitivity analyses for the primary and secondary outcomes

Dose escalation can be delayed by 4 weeks if adverse effects persist, and treatment is not recommended for patients with severe gastrointestinal disease

Private Insurance Coverage Coverage for GLP1s through private insurance varies widely

however, after the FDA approved Wegovy for a new cardiovascular indication in March 2024, the Centers for Medicare & Medicaid Services (CMS) announced that Part D plans can now cover Wegovy for this new indication